Item 9 Labs INLB Stock
Item 9 Labs Price Chart
Item 9 Labs INLB Financial and Trading Overview
| Item 9 Labs stock price | 0.0003 USD |
| Previous Close | 0.1 USD |
| Open | 0.09 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.06 - 0.09 USD |
| 52 Week Range | 0.03 - 1.07 USD |
| Volume | 12.16K USD |
| Avg. Volume | 73.06K USD |
| Market Cap | 6.12M USD |
| Beta (5Y Monthly) | 0.702112 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
INLB Valuation Measures
| Enterprise Value | 43.44M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.75125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.3120221 |
| Price/Book (mrq) | 0.10599648 |
| Enterprise Value/Revenue | 2.216 |
| Enterprise Value/EBITDA | -4.597 |
Trading Information
Item 9 Labs Stock Price History
| Beta (5Y Monthly) | 0.702112 |
| 52-Week Change | -92.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.07 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.07 USD |
| 200-Day Moving Average | 0.21 USD |
INLB Share Statistics
| Avg. Volume (3 month) | 73.06K USD |
| Avg. Daily Volume (10-Days) | 12.4K USD |
| Shares Outstanding | 101.76M |
| Float | 91.06M |
| Short Ratio | N/A |
| % Held by Insiders | 25.51% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | -156.093% |
| Operating Margin (ttm) | -56.60% |
| Gross Margin | 43.75% |
| EBITDA Margin | -48.21% |
Management Effectiveness
| Return on Assets (ttm) | -5.90% |
| Return on Equity (ttm) | -43.59% |
Income Statement
| Revenue (ttm) | 19.6M USD |
| Revenue Per Share (ttm) | 0.2 USD |
| Quarterly Revenue Growth (yoy) | -14.69% |
| Gross Profit (ttm) | 7.31M USD |
| EBITDA | -9449182 USD |
| Net Income Avi to Common (ttm) | -30593916 USD |
| Diluted EPS (ttm) | -0.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 101.15K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 33.88M USD |
| Total Debt/Equity (mrq) | 58.73 USD |
| Current Ratio (mrq) | 0.078 |
| Book Value Per Share (mrq) | 0.567 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3660230 USD |
| Levered Free Cash Flow (ttm) | 9.56M USD |
Profile of Item 9 Labs
| Country | United States |
| State | AZ |
| City | Phoenix |
| Address | 2727 North 3rd Street |
| ZIP | 85004 |
| Phone | 833 867 6337 |
| Website | https://www.item9labscorp.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 97 |
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Q&A For Item 9 Labs Stock
What is a current INLB stock price?
Item 9 Labs INLB stock price today per share is 0.0003 USD.
How to purchase Item 9 Labs stock?
You can buy INLB shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Item 9 Labs?
The stock symbol or ticker of Item 9 Labs is INLB.
Which industry does the Item 9 Labs company belong to?
The Item 9 Labs industry is Drug Manufacturers-Specialty & Generic.
How many shares does Item 9 Labs have in circulation?
The max supply of Item 9 Labs shares is 102.36M.
What is Item 9 Labs Price to Earnings Ratio (PE Ratio)?
Item 9 Labs PE Ratio is now.
What was Item 9 Labs earnings per share over the trailing 12 months (TTM)?
Item 9 Labs EPS is -0.33 USD over the trailing 12 months.
Which sector does the Item 9 Labs company belong to?
The Item 9 Labs sector is Healthcare.